Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05227105 · ClinicalTrials.gov registry record · NA
PA Moves Trial - Patient Participants
A NA study, sponsored by University of Pittsburgh.
- Active
- Registry status
- NA
- Development phase
- 880
- Enrollment target
NCT05227105: Active NA study, sponsored by University of Pittsburgh.
NCT05227105 is a NA study that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 880 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05227105, a NA study, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 880 participants
- Enrollment target
Study Summary
The purpose of this study is to address physical inactivity in rural populations in Pennsylvania.
Primary Outcome
The 11-question Morgenstern Physical Activity Questionnaire (PAQ-M) is a self-report of physical activity resulting from recreational activities, exercises, home or work activities, and chores.
Interventions
- BEHAVIORAL Physical Activity
- BEHAVIORAL Delayed intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 880 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2027-12 |
| Phase | NA |
What the registry record for NCT05227105 still lists
NCT05227105 is an interventional study that assigns participants to a tested intervention. The registered 880 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 2 interventions - of which Physical Activity is the first listed.
NCT05227105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05227105 about?
NCT05227105 is a clinical study titled "PA Moves Trial - Patient Participants". The purpose of this study is to address physical inactivity in rural populations in Pennsylvania.
What is the current status of trial NCT05227105?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 880 participants. The study started on 2023-05-23. Estimated completion is 2027-12.
What interventions are being tested in trial NCT05227105?
The interventions under investigation include: Physical Activity (BEHAVIORAL), Delayed intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05227105?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05227105's enrollment target sits among peer trials
880 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
- NCT06580314 · 880 participants · Phase 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI